Pan-cancer analysis of Sp1 with a focus on immunomodulatory roles in gastric cancer
Our pan-cancer analysis sheds light on the multifaceted role of Sp1 in tumorigenesis and underscores its potential as a prognostic and predictive biomarker for patients with GC undergoing immunotherapy.
Authors
- Zhenzhen Luo
- Libao Gong (ORCID: https://orcid.org/0000-0003-3680-2817)
- Xiao Li (ORCID: https://orcid.org/0000-0002-7078-9815)
- Yang Zhou (ORCID: https://orcid.org/0000-0002-6967-421X)
- Jinfeng Guo
- Junjie Huang (ORCID: https://orcid.org/0000-0002-2084-2198)
- Junjie Hang (ORCID: https://orcid.org/0000-0003-4750-9931)
- Xiaoli Zhou
- Lixia Wu (ORCID: https://orcid.org/0000-0002-2561-344X)
- Daijia Huang
- Jianhua Chang
- Qiuhua Duan (ORCID: https://orcid.org/0000-0003-1762-0807)
Institutions
- Sun Yat-sen University (CN)
- Chinese University of Hong Kong (HK)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
- Changzhou No.2 People's Hospital (CN)
- Shanghai Zhabei District Shibei Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1186/s12935-024-03521-z
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Natural Science Foundation of China
- Sanming Project of Medicine in Shenzhen